The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of

organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,

medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic
Introduction
concern to senior management. McKinsey serves as an adviser to the world’s leading businesses, McKinsey & Company is a
global management consulting firm that focuses on solving issues of governments, and institutions. It is recognized as a leader and
the most prestigious firm in the management consulting industry. It has been ranked No.1 for 6 consecutive years in
the Vault.com list of top consulting firms, and has been a top employer for new MBA graduates since 1996.

Type Incorporated Partnership

The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic

Industry Management consulting

Founded 1926

Headquarters New York, New York

Key people Dominic Barton, Worldwide

Managing Director

Products Management consulting services

Revenue US$6.00 Billion (est. 2008)

The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic

Employees 17,000 (9,000 consultants)

Website www.mckinsey.com
The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic
ORGANIZATION

McKinsey & Co., while formally organised as a corporation, functions as a partnership in all important respects. Its managing
director is elected for a three year term by the firm's senior shareholders (referred to as "directors", even if they are not company
directors). Each managing director can serve a maximum of three terms. At a strategic level, a number of committees are charged
with the development of policies and the making of critical decisions. McKinsey operates under a practice of "up or out”, meaning
that consultantsmust either advance in their consulting careers within a pre-defined time-frame or leave the firm.

McKinsey has about 9,000 consultants in 99 locations in 56 countries. Forbes estimated the firm's 2008 revenues at $6.0 billion.

A controversial aspect of McKinsey's practice is that it is non-exclusive, and thus a conflict of interest could arise as different teams
of consultants might work for direct competitors in an industry. This works to the company's advantage, as it does not require it to
rule out working for potential clients; furthermore, knowing that a competitor has hired McKinsey has historically been a strong
The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic
impetus for companies to seek McKinsey's assistance themselves. The policy also means McKinsey can keep its list of clients
confidential. However, because of this there is great emphasis placed on client confidentiality within the firm, and consultants are
forbidden to discuss details of their work with members of other teams. While still working for McKinsey, consultants are prohibited
from serving direct competitors unless they wait two or more years between the date they cease serving one competitor and begin
serving the next; in some cases, consultants are forbidden from ever serving a competitor.

MISION
The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic
The aim of McKenzie Consulting is to make a positive difference to our client's results. We are specialists in Convenience
Marketing and People Management.
Our approach and materials are tailored to meet the needs of the client:
We work at organisation, group and/or individual levels to achieve the necessary results.
When required, our expertise is enhanced by a network
of Associates who complement our in-house processes and programmes.
HISTORY

McKinsey & Company was founded in Chicago in 1926 by James O. ("Mac") McKinsey as James O. McKinsey and Company.
Previously, McKinsey served as an accounting professor at the University of Chicago Booth School of Business and is considered
the father of managerial accounting. In 1935 Marshall Field's became a client and soon convinced McKinsey to leave the firm and
The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic
to become its CEO in 1935. This soon led to a merger between James O. McKinsey and Company and Scovell, Wellington &
Company as McKinsey, Wellington & Company. The new firm had both an accounting practice and a management engineering
practice.

In 1937, James O. McKinsey died unexpectedly of pneumonia, which led to the division of McKinsey, Wellington & Company in
1939. C. Oliver Wellington returned to manage Scovell, Wellington & Company full time and took the accounting practice with him.
The management engineering practice was split into two affiliated firms: McKinsey & Company and McKinsey, Kearney &
Company. McKinsey & Company was led by Guy Crockett, Dick Fletcher, and Marvin Bower. McKinsey, Kearney & Company was
led by Andrew Thomas Kearney.

By 1952, McKinsey & Company formally parted ways with McKinsey, Kearney & Company, which was renamed A.T. Kearney &
Company. At the time, McKinsey was led by Marvin Bower as then managing director. Bower had joined the firm in 1933 and
served as managing director from 1950 to 1967. During his tenure he oversaw the firm's rise to global prominence and established
The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic
many of its guiding principles. Even after formally leaving McKinsey in 1967, Marvin continued to provide guidance and counsel to
the Firm for many years.

RECRUITEMENT
The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic
Marvin Bower broke with current industry practice by hiring recent graduates from the best business schools rather than among
experienced managers. Today, the firm is among the top recruiters of graduates of the top ranked business programs in the US
and overseas, in addition to hiring a significant number of people with other advanced degrees in science, medicine, engineering
and law. The firm is notable for the number of Rhodes Scholars it is able to recruit.

COMPETITORS

Four primary competitors provide strategy services to Fortune 500 entities: McKinsey & Company (McKinsey), The Boston
Consulting Group (BCG), Bain & Company (Bain), and Booz & Company(Booz). McKinsey also competes with other strategy
The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic
consulting firms, notably Roland Berger Strategy Consultants, A.T. Kearney, Oliver Wyman, Deloitte Consulting, Ernst &
Young and Monitor Group.

SERVICES
CONVENIENCE MARKETING

• Convenience Marketing Strategy

• Store Layout and Design
• Merchandise Mix and Selection
• Merchandising Training
• Supplier Management
• Category Management
The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic
• Shrinkage Management & Retail Security
• Staff Training, including Cashier Training
• Customer Service Skills

HUMAN RESOURCE MANAGEMENT

• Organisation Performance Analysis and Design

• Strategic Reviews (Strategy Formulation & Implementation)
• Strategic Review of Human Resource Management
• Culture, Climate and Human Resource Policy and Practices Audits
The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic
• Individual Performance Management Processes
• Career Development Processes
• Employment Equity Audits and Processes
• Team Building
• Customer Service Skills

LABOUR RELATIONS

• Labour Relations Consulting and Interventions

• Labour Law Workshops
• Conflict Management Workshops
• Negotiation Skills Training
• Mediation and Arbitration

Our Associate Consultants add value to our in-house expertise through their knowledge and experience in the fields of retail,
finance, politics, society, technology, ethics and the environment.
The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic
Our fee structure is highly competitive, reflecting our internal efficiencies. Each project or assignment and cost is agreed up front
with the client. For clients who require it we will structure a retainer agreement for advice and services. This secures priority
responses in providing telephonic advice and opinions, or in attending meetings at the client's premises.
 The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic

STRATEGY

Most companies’ approach to strategy involves the mistaken assumption that a predictable path
to the future can be paved from the experience of the past. In the turbulent business
environment we face today, companies must let go of the notion that strategic outcomes can be
predetermined and that enduring competitive advantage can be defined and achieved.
Instead, we define strategy as a coherent and evolving portfolio of
initiatives to drive shareholder value and long-term performance. This
change in thinking requires management to develop a “you are what you
do” perspective as opposed to “you are what you say.” In other words,
The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic

companies are defined by the initiatives they prioritize and drive, not
merely by mission and vision statements.
The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic
ur Locations

We have offices in two locations, Mumbai and Gurgaon – both tightly integrated
into the international network.

We pride ourselves on the close camaraderie between both locations. To help

sustain it, we sponsor frequent gatherings, such as our monthly town halls at
which we share experiences and update each other on new initiatives.
The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic

Welcome from the Managing Director, Adil Zainulbhai

Welcome to McKinsey & Company, India. We are delighted that you would like to learn more about
us.
Read more

Mumbai
Mumbai is the most cosmopolitan city in India and a melting pot of people from different cultures, languages,
and regions.
Read more

Gurgaon
Gurgaon is one of Delhi's major satellite cities. It is considered a part of the National Capital Region
(NCR).
Read more
 The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic

What are the most exciting aspects of working in McKinsey teams? Our consultants generally say the following:

 Addressing a difficult client problem with unique solutions.

 Observing truly 'global' teams in action, leveraging individual areas of expertise.
 Calling on the vast McKinsey global network. If a problem exists, there is a high chance that someone in McKinsey has
worked on it.

See how a global team comes together below to help an auto maker in India improve performance and productivity in the face of
competitive pressures.
The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic
To protect client confidentiality, we have created fictitious engagements to show you how we work.

A mid-size, family owned, Indian manufacturing business was facing stagnation. The three business divisions of the company
were struggling to sustain growth, thanks to competition provided by low cost Chinese companies and the demands for rapid
technology changes from customers. As a result, the company was struggling to create a sustainable growth path for itself and
subsequently improve shareholder returns.

Grasping the problem

The McKinsey team began by conducting a diagnostic across the three different business units to identify how to lower costs
and improve product quality. The team focused on strategies to enhance overall performance by taking advantage of the
company's strengths in manufacturing processes and its extensive networks. The team also realized the need to improve
middle management capabilities.

Looking for new opportunities

A series of interviews with market specialists, customers, and distributors led to credible hypotheses on demand estimates and
likely evolution of the market. An extensive benchmarking study of key metrics across lower-cost competitors enabled the team
to identify measures that would allow the company to compete on cost as well as improve product quality.

At the same time, the team evaluated sectors across the Indian economy to shortlist the ones poised for high growth and high
returns. In depth expert interviews were helpful in identifying the key success factors required to win in these sectors. Given the
client's existing strengths, the team identified two sectors that could drive the company's future growth. Once the
The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic
team developed recommendations on the existing and new businesses, they helped allocate investments, resources, and
budgets for each of the businesses.
The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic

The Automotive & Assembly Practice helps companies in virtually all areas of the automotive
industry, as well as non-automotive companies focused on assembling products. Within the
automotive industry, we serve the major automobile and commercial vehicle manufacturers, their
important component suppliers, material suppliers, and companies focused on downstream sales
and distribution. Our work has involved almost every major vehicle-system, assembly, and
component group.

Automotive OEMs (original equipment manufacturers)

Players: Passenger-car and light-truck manufacturers, heavy-truck manufacturers, agricultural

and construction equipment companies
Examples of challenges: Brand management, product launch and project management, lean
manufacturing and production, supplier management, value-chain cost reduction

Automotive Suppliers
The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic

Players: Mechanical, electrical, and electronic parts and components suppliers, materials
suppliers, equipment suppliers
Examples of challenges: Technology strategies, new business opportunities, cost reduction,
supply-chain management

Machinery Industry

Players: Assembly specialists, tool manufacturers

Examples of challenges: Building institutional skills, growth strategies, cost reductions
The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic
As economic shifts and deregulation transform the electric power, natural gas, and water
industries throughout the world, our Electric Power & Natural Gas Practice serves incumbents
and new entrants in this rapidly expanding and liberalized sector. We help clients deal with
issues related to organization, including restructuring, skill-building, and top team management;
operations, including capital investment, cost reductions, performance improvement, and
networks and logistics; and strategy, including mission, sales, economics, and procurement.

Generation and Wholesale Trading

Market knowledge, flexibility, and risk management are all essential to success in today's
competitive generation and wholesale trading markets. We advise clients on upstream strategies
and expand their understanding of generation and trading markets through modeling and
analysis.

Infrastructure Businesses (Wires and Pipes)

Consistent, excellent performance and growth are twin requirements for success as liberalization
and unbundling focus pressure on this industry. Our practice helps clients seize unbundling
opportunities, leverage existing assets and customer relations, and build new businesses
The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic
through acquisition or organic growth.

Retail Energy Services

Under liberalization, retailing of electric power, natural gas, and energy products has attracted
many new competitors to both brick-and-mortar and dot-com sectors. We help clients address
increasing competition through new products and services, as well as develop and execute
marketing strategies and core customer processes.

Capital Markets

Capital-market pressures are increasingly focused on each segment of the value chain. We work
with clients to identify opportunities and assess alternatives for increasing shareholder and
market value.

New Technologies

Distributed generation, home networks, and other emerging technologies offer significant growth
and discontinuity opportunities for many of our clients, as well as for potential new entrants. The
The Pharmaceuticals & Medical Products Practice works with a diverse spectrum of
organizations, including companies in ethical and over-the-counter (OTC) pharmaceuticals,
medical equipment, devices and supplies, diagnostics, biotechnology, and animal health. We
help clients address a full range of strategic, competitive, and operational issues.

Prescription Pharmaceuticals

We advise clients on opportunities in licensing and alliances, portfolio management, and existing
and emerging therapeutic areas and technologies. Because R&D pipelines and the search for
the next blockbuster are essential to continued strong performance, we help clients develop
sound R&D strategies. We also address issues such as sales force management, direct-to-
consumer advertising, global product launches, and life cycle management as patents expire.

OTC Medicines

As more prescription drugs become available over the counter, we help clients assess their
opportunities, explore partnerships with consumer product companies, understand the regulatory
hurdles, and measure the impact on prescription sales.

Biotechnology

The mapping of the human genome is leading the charge for new drugs and treatment regimens.
We help pharmaceutical biotechnology companies identify promising technologies, new entities,
and improved therapies based on genomics, informatics, proteomics, and other biotech
advances. We also assist clients in developing partner, acquisition, and licensing strategies.

Medical Products and Diagnostics

The medical products and diagnostics industries are large and diverse, ranging from simple
supply items to life-saving cardiovascular products. We work with clients to identify and pursue
new products, technologies, and businesses, as well as to chart strategies for global leadership,
including acquisitions.

Animal Health

Many human pharmaceuticals also have animal (farm and companion) health applications. We
help clients explore animal markets for their human products. We also develop portfolio
strategies and R&D programs to explore new drugs and formulations that meet animals' special
requirements

With 10 service lines, McKinsey's Retail Practice has helped more than half
of the world's top 100 retailers develop strategies, transform operations,
and build high-performing organizations. The descriptions that follow detail
our experience and approach to collaborating with clients to add lasting
value.

Format Strategy & Renewal

As retail lifecycles shorten, it is more important than ever for retailers to
engage in a steady cycle of renewal. Our approach helps retailers define,
design, and deliver more compelling retail formats through the application of
cutting-edge tools and processes, while strengthening the organization to
enable a continuous cycle of renewal.

Lean Retailing
McKinsey's proprietary Lean Retailing approach helps retailers transform
their operational performance by combining the principles of lean
manufacturing with the best practices of retail operations to drive dramatic
practice continually evaluates new technologies and helps clients identify and capitalize on them.

Market Analysis

We track growth and evolution of the global electric power, natural gas, and water markets,
providing public- and private-sector clients around the world with counsel and analysis on market
and regulatory reform.